Brief: Acelrx Pharma Reports First Quarter 2023 Financial Results
10/05/2023 21:20
May 10 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS FIRST QUARTER 2023
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* ACELRX PHARMACEUTICALS INC Q1 SALES $116.5 MILLION
* ACELRX PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.75
Source text for Eikon: ID:nPn23x0lDa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial